Phase Ib interim data on CDX-0159 for antihistamine-refractory chronic inducible urticaria March 29, 2021
Corectim Ointment 0.25% and 0.5% approved in Japan as treatment of pediatric atopic dermatitis March 25, 2021
First patient enrolled in phase IIa clinical study of ARQ-252 as potential treatment for vitiligo March 19, 2021
RSS